Ciclosporin in the Management of New Type 1 Reactions in Leprosy
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
Study 1A: Ciclosporin in the management of new Type 1 Reactions in Leprosy
Objective: A randomised double blind controlled trial comparing Ciclosporin and
Prednisolone,to determine whether treatment with Ciclosporin gives the same outcome in the
treatment of new Type 1 Reactions as Prednisolone.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborators:
Alert Hospital, Ethiopia Armauer Hansen Research Institute, Ethiopia Homes and Hospitals of St Giles